References
Nayak L, Abrey LE, Iwamoto FM. Intracranial dural metastases. Cancer. 2009;115:1947–53.
Campbell BA, Jhamb A, Maguire JA, Toyota B, Ma R. Meningiomas in 2009: controversies and future challenges. Am J Clin Oncol. 2009;32(1):73–85.
Shah R, Roberson GH, Curé JK. Correlation of MR imaging findings and clinical manifestations in neurosarcoidosis. AJNR Am J Neuroradiol. 2009;30(5):953–61.
Burger PC, Heinz ER, Shibata T, Kleihues P. Topographic anatomy and CT correlations in the untreated glioblastoma multiforme. J Neurosurg. 1988;68(5):698–704.
WHO classification of tumours of the central nervous system. Switzerland: WHO Press, World Health Organization; 2007.
Greenfield’s Neuropathology. 8th ed. London: Hodder Arnold; 2008.
Wakabayashi K, Shimura T, Mizutani N, Koide A, Yamagiwa O, Mori F, et al. Primary intracranial solitary leptomeningeal glioma: a report of 3 cases. Clin Neuropathol. 2002;21(5):206–13.
Grabb PA, Albright AL, Pang D. Dissemination of supratentorial malignant gliomas via the cerebrospinal fluid in children. Neurosurg. 1992;30(1):64–71.
Vertosick FT Jr, Selker RG. Brain stem and spinal metastases of supratentorial glioblastoma multiforme: a clinical series. Neurosurg. 1990;27(4):516–22.
Arita N, Taneda M, Hayakawa T. Leptomeningeal dissemination of malignant gliomas. Incidence, diagnosis and outcome. Acta Neurochir (Wien). 1994;126(2–4):84–92.
Awad I, Bay JW, Rogers L. Leptomeningeal metastasis from supratentorial malignant gliomas. Neurosurg. 1986;19(2):247–51.
Schuss P, Ulrich CT, Harter PN, Tews DS, Seifert V, Franz K. Gliosarcoma with bone infiltration and extracranial growth: case report and review of literature. J Neurooncol. 2011;103(3):765–70.
Pedersen PH, Rucklidge GJ, Mork SJ, Terzis AJ, Engebraaten O, Lund-Johansen M, et al. Leptomeningeal tissue: a barrier against brain tumor cell invasion. J Natl Cancer Inst. 1994;86(21):1593–9.
Pohar S, Taylor W, Chandan VS, Shah H, Sagerman RH. Primary presentation of glioblastoma multiforme with leptomeningeal metastasis in the absence of previous craniotomy: a case report. Am J Clin Oncol. 2004;27(6):640–1.
Schuster H, Jellinger K, Gund A, Regele H. Extracranial metastases of anaplastic cerebral gliomas. Acta Neurochir (Wien). 1976;35(4):247–59.
Alatakis S, Malham GM, Thien C. Spinal leptomeningeal metastasis from cerebral glioblastoma multiforme presenting with radicular pain: case report and literature review. Surg Neurol. 2001;56(1):33–8.
Shuangshoti S, Rushing EJ, Mena H, Olsen C, Sandberg GD. Supratentorial extraventricular ependymal neoplasms: a clinicopathologic study of 32 patients. Cancer. 2005;103(12):2598–605.
Pompili A, Calvosa F, Caroli F, Mastrostefano R, Occhipinti E, Raus L, et al. The transdural extension of gliomas. J Neurooncol. 1993;15(1):67–74.
Buhl R, Barth H, Hugo HH, Hutzelmann A, Mehdorn HM. Spinal drop metastases in recurrent glioblastoma multiforme. Acta Neurochir (Wien). 1998;140(10):1001–5.
Kato H, Fujimura M, Kumabe T, Ishioka C, Kanamaru R, Yoshimoto T. PTEN gene mutation and high MIB-1 labeling index may contribute to dissemination in patients with glioblastoma. J Clin Neurosci. 2004;11(1):37–41.
Hamilton MG, Tranmer BI, Hagen NA. Supratentorial glioblastoma with spinal cord intramedullary metastasis. Can J Neurol Sci. 1993;20(1):65–8.
Lindsay A, Holthouse D, Robbins P, Knuckey N. Spinal leptomeningeal metastases following glioblastoma multiforme treated with radiotherapy. J Clin Neurosci. 2002;9(6):725–8.
Asano K, Kubo O, Tajika Y, Takakura K, Suzuki S. Expression of cadherin and CSF dissemination in malignant astrocytic tumors. Neurosurg Rev. 2000;23(1):39–44.
Korshunov A, Sycheva R, Golanov A, Pronin I. Gains at the 1p36 chromosomal region are associated with symptomatic leptomeningeal dissemination of supratentorial glioblastomas. Am J Clin Pathol. 2007;127(4):585–90.
Ohgaki H, Dessen P, Jourde B, Horstmann S, Nishikawa T, Di Patre PL, et al. Genetic pathways to glioblastoma: a population-based study. Cancer Res. 2004;64(19):6892–9.
Sato A, Sakurada K, Kumabe T, Sasajima T, Beppu T, Asano K, et al. Association of stem cell marker CD133 expression with dissemination of glioblastomas. Neurosurg Rev. 2010;33(2):175–84.
Korshunov A, Sycheva R, Golanov A. The prognostic relevance of molecular alterations in glioblastomas for patients age < 50 yrs. Cancer. 2005;104(4):825–32.
Nakada M, Kita D, Futami K, Yamashita J, Fujimoto N, Sato H, et al. Roles of membrane type 1 matrix metalloproteinase and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of human malignant glioma. J Neurosurg. 2001;94(3):464–73.
Komatsu K, Nakanishi Y, Nemoto N, Hori T, Sawada T, Kobayashi M. Expression and quantitative analysis of matrix metalloproteinase-2 and −9 in human gliomas. Brain Tumor Pathol. 2004;21(3):105–12.
Onda K, Tanaka R, Takahashi H, Takeda N, Ikuta F. Cerebral glioblastoma with cerebrospinal fluid dissemination: a clinicopathological study of 14 cases examined by complete autopsy. Neurosurg. 1989;25(4):533–40.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Taschner, C., Brendecke, S., Weyerbrock, A. et al. Freiburg Neuropathology Case Conference: Widespread Mass Lesions After Resection of a Glioblastoma Multiforme. Clin Neuroradiol 22, 375–380 (2012). https://doi.org/10.1007/s00062-012-0179-5
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00062-012-0179-5